Literature DB >> 2105277

Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis.

J P Woods1, J G Cannon.   

Abstract

Accidental nasopharyngeal colonization of a laboratory worker by a human disease isolate of Neisseria meningitidis allowed us to examine the variation in expression of outer membrane components and the host humoral response over time. There were quantitative differences in class 1 outer membrane protein expression in nasopharyngeal isolates obtained at different times. Isolates also showed phase variation of all four class 5 outer membrane proteins produced by the colonizing strain. After colonization, we detected new host serum immunoglobulin G antibodies directed against class 1, class 5, and H.8 outer membrane proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105277      PMCID: PMC258496          DOI: 10.1128/iai.58.2.569-572.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

Review 1.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

2.  Common mechanism controlling phase and antigenic variation in pathogenic neisseriae.

Authors:  A Stern; T F Meyer
Journal:  Mol Microbiol       Date:  1987-07       Impact factor: 3.501

3.  Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa.

Authors:  B A Crowe; R A Wall; B Kusecek; B Neumann; T Olyhoek; H Abdillahi; M Hassan-King; B M Greenwood; J T Poolman; M Achtman
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

Review 4.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

5.  Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins.

Authors:  R E Mandrell; W D Zollinger
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

6.  Isolation by streptonigrin enrichment and characterization of a transferrin-specific iron uptake mutant of Neisseria meningitidis.

Authors:  D W Dyer; W McKenna; J P Woods; P F Sparling
Journal:  Microb Pathog       Date:  1987-11       Impact factor: 3.738

7.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

8.  Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection.

Authors:  C R Tinsley; J E Heckels
Journal:  J Gen Microbiol       Date:  1986-09

9.  Reversible phase variation of expression of Neisseria meningitidis class 5 outer membrane proteins and their relationship to gonococcal proteins II.

Authors:  T H Kawula; E L Aho; D S Barritt; D G Klapper; J G Cannon
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

10.  Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A.

Authors:  M Achtman; M Neibert; B A Crowe; W Strittmatter; B Kusecek; E Weyse; M J Walsh; B Slawig; G Morelli; A Moll
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  15 in total

Review 1.  The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis.

Authors:  C D Bayliss; D Field; E R Moxon
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  HmbR, a hemoglobin-binding outer membrane protein of Neisseria meningitidis, undergoes phase variation.

Authors:  A R Richardson; I Stojiljkovic
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

3.  Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.

Authors:  Gestur Vidarsson; Natasja Overbeeke; Annette M Stemerding; Germie van den Dobbelsteen; Peter van Ulsen; Peter van der Ley; Mogens Kilian; Jan G J van de Winkel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.

Authors:  M G Danelli; N M Batoreu; M D Lacerda; C R Ferreira; J D Cardoso; J M Peralta; C E Frasch
Journal:  Curr Microbiol       Date:  1995-09       Impact factor: 2.188

6.  Transcriptome analysis of Neisseria meningitidis during infection.

Authors:  Guido Dietrich; Sebastian Kurz; Claudia Hübner; Christian Aepinus; Stephanie Theiss; Matthias Guckenberger; Ursula Panzner; Jacqueline Weber; Matthias Frosch
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

7.  Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.

Authors:  Mohamed Alamro; Fadil A Bidmos; Hannah Chan; Neil J Oldfield; Emma Newton; Xilian Bai; Jack Aidley; Rory Care; Claire Mattick; David P J Turner; Keith R Neal; Dlawer A A Ala'aldeen; Ian Feavers; Ray Borrow; Christopher D Bayliss
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 8.  Interaction of pathogenic neisseriae with nonphagocytic cells.

Authors:  X Nassif; M So
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype.

Authors:  Christopher D Bayliss; J Claire Hoe; Katherine Makepeace; Patricia Martin; Derek W Hood; E Richard Moxon
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

Review 10.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.